The role of regulatory T lymphocytes in asthma pathogenesis

Current Allergy and Asthma Reports

Volumn 5, Issue 2, 2005, Pages 136-141

  Robinson, Douglas S ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CORTICOSTEROID; DEXAMETHASONE; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA;

ASTHMA; CYTOKINE PRODUCTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PATHOGENESIS; REVIEW; SENSITIZATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 14744305486     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-005-0087-8     Document Type: Review

References (60)

1. Robinson DS: Th-2 cytokines in allergic disease. Br Med Bull 2000, 56:956-968.
2. Busse WW, Lemanske RF Jr: Asthma. N Engl J Med 2001, 344:350-362.
3. Sakaguchi S: Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000, 101:455-458.
4. Shevach EM: CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002, 2:389-400.
5. Maloy KJ, Powrie F: Regulatory T cells in the control of immune pathology. Nat Immunol 2001, 2:816-822.
6. Sakaguchi S, Sakaguchi N, Asano M, et al.: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995, 155:1151-1164.
7. Mottet C, Uhlig HH, Powrie F: Cutting edge: cure of colitis by cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 2003, 170:3939-3943.
8. Jordan MS, Boesteanu A, Reed AJ, et al.: Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2001, 2:301-306.
9. Bluestone JA, Abbas AK: Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003, 3:253-257.
10. Thornton AM, Shevach EM: CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998, 188:287-296.
11. Levings MK, Sangregorio R, Roncarolo M-G: Human CD25+CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 2001, 193:1295-1302.
12. Jonuleit H, Schmitt E, Stassen M, et al.: Identification and functional characterization of human CD4+CD25+ T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001, 193:1285-1294.
13. Stephens LA, Mottet C, Mason D, Powrie F: Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 2001, 31:1247-1254.
14. Dieckmann D, Plottner H, Berchtold S, et al.: Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood. J Exp Med 2001, 193: 303-1310.
15. Taams LS, Smith J, Rustin MH, et al.: Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol 2001, 31: 122-1131.
16. Ng WF, Duggan PJ, Ponchel F, et al.: Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood 2001, 98:2736-2744.
17. Groux H, O'Garra A, Bigler M, et al.: A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997, 389:737-742.
18. Cottrez F, Hurst SD, Coffman RL, Groux H: T regulatory cells 1 inhibit a Th2-specific response in vivo. J Immunol 2000, 165:4848-4853.
19. Levings MK, Sangregorio R, Galbiati F, et al.: IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 2001, 166:5530-5539.
20. Barrat FJ, Cua DJ, Boonstra A, et al.: In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002, 195: 03-616.
21. Nguyen X, Robinson DS: Fluticasone propionate increases CD4CD25 T regulatory cell suppression of allergen-stimulated CD4CD25 T cells by an IL-10-dependent mechanism. J Allergy Clin Immunol 2004, 114:296-301.
22. Sundstedt A, O'Neill EJ, Nicolson KS, Wraith DC: Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. J Immunol 2003, 170:1240-1248.
23. Chen Y, Kuchroo VK, Inobe J, et al.: Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994, 265:1237-1240.
24. Cohn L, Homer RJ, Niu N, Bottomly K: T helper 1 cells and interferon gamma regulate allergic airway inflammation and mucus production. J Exp Med 1999, 190:1309-1318.
25. Szabo SJ, Sullivan BM, Stemmann C, et al.: Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 2002, 295:338-342.
26. Finotto S, Neurath MF, Glickman JN, et al.: Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 2002, 295:336-338.
27. Stassen M, Jonuleit H, Muller C, et al.: Differential regulatory capacity of CD25+ T regulatory cells and preactivated CD25+ T regulatory cells on development, functional activation, and proliferation of Th2 cells. J Immunol 2004, 173:267-274.
28. Cosmi L, Liotta F, Angeli R, et al.: Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines. Blood 2004, 103:3117-3121.
29. Ling EM, Smith T, Nguyen XD, et al.: Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004, 363:608-615.
30. Suto A, Nakajima H, Kagami SI, et al.: Role of CD4(+) CD25(+) regulatory T cells in T helper 2 cell-mediated allergic inflammation in the airways. Am J Respir Crit Care Med 2001, 164:680-687.
31. Jaffar Z, Sivakuru T, Roberts K: CD4+CD25+ T cells regulate airway eosinophilic inflammation by modulating the Th2 cell phenotype. J Immunol 2004, 172:3842-3849.
32. Hadeiba H, Locksley RM: Lung CD25 CD4 regulatory T cells suppress type 2 immune responses but not bronchial hyperreactivity. J Immunol 2003, 170:5502-5510.
33. Chen W, Jin W, Hardegen N, et al.: Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003, 198:1875-1886.
34. McMenamin C, Pimm C, McKersey M, Holt PG: Regulation of IgE responses to inhaled antigen in mice by antigen-specific gamma delta T cells. Science 1994, 265:1869-1871.
35. Ostroukhova M, Seguin-Devaux C, Oriss TB, et al.: Tolerance induced by inhaled antigen involves CD4(+) T cells expressing membrane-bound TGF-beta and FOXP3. J Clin Invest 2004, 114: 8-38.
36. Akbari O, Freeman GJ, Meyer EH, et al.: Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002, 8:1024-1032.
37. Akbari O, DeKruyff RH, Umetsu DT: Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001, 2:725-731.
38. Zuany-Amorim C, Sawicka E, Manlius C, et al.: Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 2002, 8: 25-629.
39. Hoyne GF, Le Roux I, Corsin-Jimenez M, et al.: Serrate1-induced notch signalling regulates the decision between immunity and tolerance made by peripheral CD4(+) T cells. Int Immunol 2000, 12:177-185.
40. Tiemessen MM, Van Hoffen E, Knulst AC, et al.: CD4 CD25 regulatory T cells are not functionally impaired in adult patients with IgE-mediated cow's milk allergy. J Allergy Clin Immunol 2001, 110:934-936.
41. Bellinghausen I, Klostermann B, Knop J, Saloga J: Human CD4+CD25+ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production. J Allergy Clin Immunol 2003, 111:862-868.
42. Baecher-Allan C, Hafler DA: Suppressor T cells in human diseases. J Exp Med 2004, 200:273-276.
43. Akdis M, Verhagen J, Taylor A, et al.: Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004, 199:1567-1575.
44. Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
45. Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4:330-336.
46. Khattri R, Cox T, Yasayko SA, Ramsdell F: An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003, 4:337-342.
47. Wildin RS, Ramsdell F, Peake J, et al.: X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001, 27: 8-20.
48. Vieira PL, Christensen JR, Minaee S, et al.: IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J Immunol 2004, 172:5986-5993.
49. von Bubnoff D, Fimmers R, Bogdanow M, et al.: Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure. Clin Exp Allergy 2004, 34:1056-1063.
50. von Bubnoff D, Matz H, Frahnert C, et al.: FcepsilonRI induces the tryptophan degradation pathway involved in regulating T cell responses. J Immunol 2002, 169: 810-1816.
51. Francis JN, Till SJ, Durham SR: Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003, 111:1255-1261.
52. Jutel M, Akdis M, Budak F, et al.: IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003, 33:1205-1214.
53. Oldfield WL, Larche M, Kay AB: Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet 2002, 360:47-53.
54. Moller C, Dreborg S, Ferdousi HA, et al.: Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002, 109:251-256.
55. Baldini M, Lohman IC, Halonen M, et al.: A polymorphism* in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999, 20:976-983.
56. Eder W, Klimecki W, Yu L, et al.: Toll-like receptor 2 as a major gene for asthma in children of European farmers. J Allergy Clin Immunol 2003, 113:482-488.
57. Eisenbarth SC, Piggott DA, Huleatt JW, et al.: Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 2002, 196: 645-1651.
58. Pasare C, Medzhitov R: Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003, 299:1033-1036.
59. Platts-Mills T, Vaughan J, Squillace S, et al.: Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet 2001, 357:752-756.
60. Flood-Page P, Menzies-Gow A, Phipps S, et al.: Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 2003, 112:1029-1036.